In a recent press release, L&K Spine Inc. announced a celebratory achievement in the field of spine surgery. The cutting-edge PathLoc-TM, PLIF/TLIF Expandable Cage has successfully completed 500 level implantation as of 29 June 2023, innovating the way they treat spinal conditions and providing better outcomes for patients.
The Key features of the PathLoc-TM:
- Precision Engineering: The meticulously designed Pathloc-TM allows for accurate placement and optimal fit within the disc space. Its expandable nature allows for customization based on the patient’s specific anatomical condition.
- The ‘H’ shaped endplate: The ‘H’ shape of the PathLoc-TM’s endplate enables 20 degrees of hyper-lordosis, and bone graft can be directly injected in between the spinal endplate and implant through the space of the H shape design.
The milestone of 500 Level implantation using the PathLoc-TM highlights its remarkable clinical performance and widespread acceptance within the spinal interbody community. Patients who have undergone spine surgery with the PathLoc-TM have reported significant pain relief, increased mobility, and improved quality of life.
L&K BIOMED, a manufacturer of spinal implants, with a complete portfolio of ALIF, ATP, LLIF, PLIF, and TLIF approach expandable cages. L&K has started a massive data collection project of the world’s first curved lateral expandable cage in the United States. The AccelFix-XTP is an expandable cage that can be used for both LLIF and ATP approach, due to its unique and patented curvature design, it greatly reduces the risk of compromising the contralateral nerve during insertion.
L&K Spine Inc., a subsidiary of L&K BIOMED, is a U.S. based medical device company focused on marketing products for the surgical treatment of spine disorders.
L&K Spine INC